Biomarkers in colorectal cancer: Added value or just added expense? Journal Article


Author: Saltz, L. B.
Article Title: Biomarkers in colorectal cancer: Added value or just added expense?
Keywords: immunohistochemistry; signal transduction; survival rate; gene mutation; glucuronosyltransferase 1a1; cancer patient; nuclear magnetic resonance imaging; clinical practice; colorectal cancer; biological marker; animals; gene targeting; computer assisted tomography; gene expression; ca 19-9 antigen; carcinoembryonic antigen; epidermal growth factor receptor; tumor markers, biological; genotype; editorial; mutational analysis; cetuximab; irinotecan; panitumumab; colorectal neoplasms; cost effectiveness analysis; survival time; patient care; tumor cell; imaging and display; cost benefit analysis; virus oncogene
Journal Title: Expert Review of Molecular Diagnostics
Volume: 8
Issue: 3
ISSN: 1473-7159
Publisher: Informa Healthcare  
Date Published: 2008-05-01
Start Page: 231
End Page: 233
Language: English
DOI: 10.1586/14737159.8.3.231
PUBMED: 18598101
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 3" - "Export Date: 17 November 2011" - "CODEN: ERMDC" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz